Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 5/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 4/20 | 0.31 |
| ▸ | MAOB | P27338 | 4/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | CDC7 | O00311 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709385 | 0.92 | TOP1 (0.40) | TOP1CYP19A1 | |
| SCHEMBL22148812 | 0.89 | MAPK14 (0.37) | MAOAMAOBACHECDC7CDK2 | |
| SCHEMBL22148726 | 0.86 | TOP1 (0.34) | TOP1 | |
| SCHEMBL22148529 | 0.83 | TOP1 (0.40) | TOP1 | |
| SCHEMBL30709206 | 0.83 | MAOA (0.36) | CYP19A1MAOAMAOBACHEALOX5 | |
| SCHEMBL22148917 | 0.83 | MAOA (0.36) | CYP19A1MAOAMAOBACHEALOX5 | |
| SCHEMBL22148660 | 0.83 | MAOA (0.36) | CYP19A1MAOAMAOBACHEALOX5 | |
| SCHEMBL30709686 | 0.83 | MAPK14 (0.40) | — | |
| SCHEMBL22148776 | 0.83 | SMN1; SMN2 (0.35) | CYP19A1ACHEALOX5 | |
| SCHEMBL30709490 | 0.83 | SMN1; SMN2 (0.35) | CYP19A1ACHEALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | TOP1 2727/4885CYP19A1 457/4885MAOA 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.